New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
May 12, 2014
09:56 EDTINSYInsys Therapeutics drops after cautious mention by Bronte Capital
Reference Link
News For INSY From The Last 14 Days
Check below for free stories on INSY the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
August 1, 2014
13:08 EDTINSYInsys Therapeutics weakness a buying opportunity, says JMP Securities
JMP Securities said Insys Therapeutics (INSY) is weak on concerns that Subsys may be added to Express Scripts' (ESRX) exclusion list in 2015. The analyst does not know if it will or not be added but said the potential impact would not be material to sales or growth because the product is not included in any PBM preferred formula positions and has prior authorization requirements. The analyst would use weakness as a buying opportunity and reiterates its Outperform rating and $65 price target.
10:23 EDTINSYHigh option volume stocks
Subscribe for More Information
July 31, 2014
14:59 EDTINSYInsys sinks after analyst sees drug to be excluded from coverage
Subscribe for More Information
July 18, 2014
10:48 EDTINSYHigh option volume stocks
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use